Check the latest paper pattern, marking scheme, and topic-wise weightage for the 2026 exam scheduled on 27 March to prepare ...
They recognize AI’s challenges and long-term unknowns, but they also believe that with proper guardrails, AI is already ...
As we expected, the “Vista” supercomputer that the Texas Advanced Computing Center installed last year as a bridge between ...
IMDEX Limited (ASX: IMD) (“IMDEX” or “the Company”) is pleased to announce it has entered into binding agreements to acquire 100% ...
Under the UAE’s national education strategy and Ras Al Khaimah’s Vision 2030, the emirate’s education sector is undergoing a ...
Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an ...
Check the Best IIM Mumbai UG Program 2026, including eligibility criteria, course fees, admission process, and more. Get all ...
A science-first biotech fund is leaning deeper into one company just as its lead program delivers some compelling early neuro ...
Recent measurements recorded by NJIT’s new network of radio telescopes show how a rare sequence of intense flares from Nov. 9 ...
Overall, ESMO 2025 reinforced the growing potential of biomarkers in cancer, with AI integration accelerating adoption. As ...
Today, Novo Nordisk released topline results from their phase 3 Evoke and Evoke+ trials of semaglutide, an oral GLP-1 drug, in individuals with early-stage Alzheimer's disease, showing the trials did ...
Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback